These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15718159)

  • 1. Thalidomide as a novel therapeutic agent: new uses for an old product.
    Teo SK; Stirling DI; Zeldis JB
    Drug Discov Today; 2005 Jan; 10(2):107-14. PubMed ID: 15718159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic use of immunomodulatory drugs in the treatment of multiple myeloma.
    Raje N; Hideshima T; Anderson KC
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1239-47. PubMed ID: 17020458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC-5013 (Celgene).
    Mitsiades CS; Mitsiades N
    Curr Opin Investig Drugs; 2004 Jun; 5(6):635-47. PubMed ID: 15242253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of immunomodulatory drugs in the treatment of solid tumors.
    Dalgleish A; Galustian C
    Future Oncol; 2010 Sep; 6(9):1479-84. PubMed ID: 20919830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of thalidomide and its analogues: implications for anticancer therapy.
    Teo SK
    AAPS J; 2005 Mar; 7(1):E14-9. PubMed ID: 16146335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide and lenalidomide in the treatment of multiple myeloma.
    Kumar S; Rajkumar SV
    Eur J Cancer; 2006 Jul; 42(11):1612-22. PubMed ID: 16750621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide and its dermatologic uses.
    Paghdal KV; Schwartz R
    Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies.
    Sharma RA; Steward WP; Daines CA; Knight RD; O'Byrne KJ; Dalgleish AG
    Eur J Cancer; 2006 Sep; 42(14):2318-25. PubMed ID: 16899362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lenalidomide in the treatment of multiple myeloma and myelodysplastic syndrome.
    Maier SK; Hammond JM
    Ann Pharmacother; 2006 Feb; 40(2):286-9. PubMed ID: 16403850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatologic and nondermatologic uses of thalidomide.
    Nasca MR; Micali G; Cheigh NH; West LE; West DP
    Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide in solid tumors.
    Segler A; Tsimberidou AM
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1393-406. PubMed ID: 22584909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thalidomide: new uses for an old drug].
    Wu KL; Sonneveld P
    Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the relapsed/refractory myeloma patient: strategies incorporating lenalidomide.
    Richardson P
    Semin Hematol; 2005 Oct; 42(4 Suppl 4):S9-15. PubMed ID: 16344100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide in multiple myeloma: current experimental and clinical data.
    Cives M; Milano A; Dammacco F; Silvestris F
    Eur J Haematol; 2012 Apr; 88(4):279-91. PubMed ID: 22085323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide and its role in the management of multiple myeloma.
    Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating chronic lymphocytic leukemia with thalidomide and lenalidomide.
    Giannopoulos K; Mertens D; Stilgenbauer S
    Expert Opin Pharmacother; 2011 Dec; 12(18):2857-64. PubMed ID: 22098228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lenalidomide in the treatment of multiple myeloma: a review.
    Armoiry X; Aulagner G; Facon T
    J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel lenalidomide-based combinations for treatment of multiple myeloma.
    Cives M; Simone V; Brunetti O; Longo V; Silvestris F
    Crit Rev Oncol Hematol; 2013 Jan; 85(1):9-20. PubMed ID: 22809697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lenalidomide: new drug. Myeloma: many questions remain unanswered.
    Prescrire Int; 2008 Dec; 17(98):230-2. PubMed ID: 19422142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs for myeloma.
    Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K
    Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.